Home › Drug Resistant Epilepsy › NCT05600738
Network Effects of Therapeutic Deep Brain Stimulation
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * diagnosis of Epilepsy * undergoing neuromodulation therapy with clinically implanted neuromodulation devices (DBS, RNS) * followed in the outpatient epilepsy clinic Exclusion Criteria: * pregnant women * active psychosis, major depression, or suicidal ideation in the preceding year * Intelligence quotient (IQ) less than 70 as measured by clinical neuropsychological evaluation * Do not agree to share their medical records for research purposes
About the study
The purpose of this study is to map the acute, short-term cortical evoked responses to thalamic electrical stimulation in persons with intractable epilepsy
What is being tested
- RNS/DBS activation (device)
Sponsor: The University of Texas Health Science Center, Houston · Participants: 25 · Started: Aug 26, 2022
Contact the study team
- Sandipan Pati, MD · Phone: 713-500-7925
- Jaison Hampson · Phone: 713-500-7754
Official record on ClinicalTrials.gov — NCT05600738
Locations in the U.S.
| Texas | The University of Texas Health Science Center at Houston, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.